Search Thermo Fisher Scientific
Invitrogen
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promotions']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.viewpromo']}}
{{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.promocode']}}: {{promo.promoCode}} {{promo.promoTitle}} {{promo.promoDescription}}. {{$productOrderCtrl.translations['antibody.pdp.commerceCard.promotion.learnmore']}}
Nebratamig is a monoclonal antibody under investigation for the treatment of certain cancers. While specific data regarding its target antigens and therapeutic mechanisms are not yet publicly available monoclonal antibodies such as Nebratamig are typically designed to recognize and bind to specific proteins on cancer cells aiding in their destruction by the immune system. Clinical trials are necessary to assess its potential benefits and risks.
仅用于科研。不用于诊断过程。未经明确授权不得转售。